Novo Holdings A/S as of Sept. 30, 2024
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 37 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 14.6 | $294M | 1.0M | 283.16 | |
| Tempus Ai Cl A (TEM) | 11.5 | $231M | 4.1M | 56.60 | |
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 9.2 | $186M | 3.5M | 53.15 | |
| Edgewise Therapeutics (EWTX) | 7.4 | $148M | 5.5M | 26.69 | |
| Corcept Therapeutics Incorporated (CORT) | 5.5 | $112M | 2.4M | 46.28 | |
| Asml Holding N V N Y Registry Shs (ASML) | 5.5 | $111M | 133k | 833.25 | |
| salesforce (CRM) | 5.0 | $101M | 369k | 273.71 | |
| Vaxcyte (PCVX) | 4.3 | $86M | 750k | 114.27 | |
| Mirum Pharmaceuticals (MIRM) | 2.9 | $59M | 1.5M | 39.00 | |
| Miragen Therapeutics (VRDN) | 2.7 | $54M | 2.4M | 22.75 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.6 | $53M | 501k | 106.12 | |
| Insmed Com Par $.01 (INSM) | 2.6 | $53M | 725k | 73.00 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.5 | $51M | 1.0M | 51.10 | |
| Cable One (CABO) | 2.1 | $41M | 118k | 349.79 | |
| Arrivent Biopharma (AVBP) | 1.8 | $35M | 1.5M | 23.50 | |
| Merus N V (MRUS) | 1.7 | $35M | 700k | 49.96 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $34M | 490k | 70.29 | |
| Celldex Therapeutics Com New (CLDX) | 1.6 | $33M | 964k | 33.99 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $33M | 118k | 275.03 | |
| Pharvaris N V (PHVS) | 1.6 | $32M | 1.7M | 18.52 | |
| Lanzatech Global (LNZA) | 1.5 | $30M | 16M | 1.91 | |
| Brookfield Asset Managmt Cl A Lmt Vtg Shs (BAM) | 1.5 | $30M | 627k | 47.29 | |
| Cargo Therapeutics (CRGX) | 1.4 | $29M | 1.5M | 18.45 | |
| Amicus Therapeutics (FOLD) | 1.3 | $27M | 2.5M | 10.68 | |
| Rocket Pharmaceuticals (RCKT) | 1.0 | $20M | 1.1M | 18.47 | |
| Zenas Biopharma | 1.0 | $20M | 1.2M | 16.92 | |
| 4d Molecular Therapeutics In (FDMT) | 0.8 | $16M | 1.5M | 10.81 | |
| Blueprint Medicines (BPMC) | 0.8 | $16M | 175k | 92.50 | |
| Verve Therapeutics (VERV) | 0.6 | $12M | 2.4M | 4.84 | |
| Lexeo Therapeutics (LXEO) | 0.5 | $10M | 1.1M | 9.04 | |
| Kyverna Therapeutics (KYTX) | 0.4 | $9.0M | 1.9M | 4.89 | |
| Metagenomi (MGX) | 0.2 | $3.9M | 1.8M | 2.17 | |
| Io Biotech (IOBT) | 0.2 | $3.5M | 3.4M | 1.05 | |
| Abcellera Biologics (ABCL) | 0.1 | $2.9M | 1.1M | 2.60 | |
| Marqeta Class A Com (MQ) | 0.1 | $2.2M | 442k | 4.92 | |
| Galecto Com New | 0.1 | $1.2M | 100k | 12.15 | |
| Spero Therapeutics (SPRO) | 0.0 | $628k | 469k | 1.34 |
